vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and CENTRAL PACIFIC FINANCIAL CORP (CPF). Click either name above to swap in a different company.
CENTRAL PACIFIC FINANCIAL CORP is the larger business by last-quarter revenue ($72.9M vs $44.9M, roughly 1.6× AbCellera Biologics Inc.). CENTRAL PACIFIC FINANCIAL CORP runs the higher net margin — 28.4% vs -19.9%, a 48.4% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 6.0%). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs 6.7%).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Central Pacific Bank (CPB) is an American regional commercial bank located throughout the state of Hawaii.
ABCL vs CPF — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $72.9M |
| Net Profit | $-8.9M | $20.7M |
| Gross Margin | — | — |
| Operating Margin | -63.7% | — |
| Net Margin | -19.9% | 28.4% |
| Revenue YoY | 788.4% | 6.0% |
| Net Profit YoY | 73.9% | 16.7% |
| EPS (diluted) | $-0.03 | $0.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $72.9M | ||
| Q4 25 | $44.9M | $76.3M | ||
| Q3 25 | $9.0M | $74.8M | ||
| Q2 25 | $17.1M | $72.8M | ||
| Q1 25 | $4.2M | $68.8M | ||
| Q4 24 | $5.0M | $58.4M | ||
| Q3 24 | $6.5M | $66.6M | ||
| Q2 24 | $7.3M | $64.0M |
| Q1 26 | — | $20.7M | ||
| Q4 25 | $-8.9M | $22.9M | ||
| Q3 25 | $-57.1M | $18.6M | ||
| Q2 25 | $-34.7M | $18.3M | ||
| Q1 25 | $-45.6M | $17.8M | ||
| Q4 24 | — | $11.3M | ||
| Q3 24 | $-51.1M | $13.3M | ||
| Q2 24 | $-36.9M | $15.8M |
| Q1 26 | — | — | ||
| Q4 25 | -63.7% | 37.0% | ||
| Q3 25 | -851.8% | 31.6% | ||
| Q2 25 | -290.2% | 32.8% | ||
| Q1 25 | -1479.6% | 32.8% | ||
| Q4 24 | — | 23.0% | ||
| Q3 24 | -1439.4% | 25.6% | ||
| Q2 24 | -1276.2% | 32.2% |
| Q1 26 | — | 28.4% | ||
| Q4 25 | -19.9% | 30.0% | ||
| Q3 25 | -637.8% | 24.8% | ||
| Q2 25 | -203.3% | 25.1% | ||
| Q1 25 | -1077.2% | 25.8% | ||
| Q4 24 | — | 19.4% | ||
| Q3 24 | -785.4% | 20.0% | ||
| Q2 24 | -504.3% | 24.7% |
| Q1 26 | — | $0.78 | ||
| Q4 25 | $-0.03 | $0.85 | ||
| Q3 25 | $-0.19 | $0.69 | ||
| Q2 25 | $-0.12 | $0.67 | ||
| Q1 25 | $-0.15 | $0.65 | ||
| Q4 24 | — | $0.42 | ||
| Q3 24 | $-0.17 | $0.49 | ||
| Q2 24 | $-0.13 | $0.58 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | — |
| Total DebtLower is stronger | — | $76.5M |
| Stockholders' EquityBook value | $966.9M | $593.9M |
| Total Assets | $1.4B | $7.5B |
| Debt / EquityLower = less leverage | — | 0.13× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $128.5M | — | ||
| Q3 25 | $83.2M | — | ||
| Q2 25 | $92.4M | — | ||
| Q1 25 | $159.3M | — | ||
| Q4 24 | $156.3M | — | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — |
| Q1 26 | — | $76.5M | ||
| Q4 25 | — | $76.5M | ||
| Q3 25 | — | $131.5M | ||
| Q2 25 | — | $131.5M | ||
| Q1 25 | — | $131.4M | ||
| Q4 24 | — | $156.3M | ||
| Q3 24 | — | $156.3M | ||
| Q2 24 | — | $156.2M |
| Q1 26 | — | $593.9M | ||
| Q4 25 | $966.9M | $592.6M | ||
| Q3 25 | $964.0M | $588.1M | ||
| Q2 25 | $1.0B | $568.9M | ||
| Q1 25 | $1.0B | $557.4M | ||
| Q4 24 | $1.1B | $538.4M | ||
| Q3 24 | $1.1B | $543.7M | ||
| Q2 24 | $1.1B | $518.6M |
| Q1 26 | — | $7.5B | ||
| Q4 25 | $1.4B | $7.4B | ||
| Q3 25 | $1.4B | $7.4B | ||
| Q2 25 | $1.4B | $7.4B | ||
| Q1 25 | $1.3B | $7.4B | ||
| Q4 24 | $1.4B | $7.5B | ||
| Q3 24 | $1.4B | $7.4B | ||
| Q2 24 | $1.4B | $7.4B |
| Q1 26 | — | 0.13× | ||
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.23× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.29× | ||
| Q3 24 | — | 0.29× | ||
| Q2 24 | — | 0.30× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | — |
| Free Cash FlowOCF − Capex | $-44.6M | — |
| FCF MarginFCF / Revenue | -99.4% | — |
| Capex IntensityCapex / Revenue | 21.9% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-34.7M | $97.5M | ||
| Q3 25 | $-52.6M | $22.2M | ||
| Q2 25 | $-32.4M | $34.3M | ||
| Q1 25 | $-11.6M | $20.4M | ||
| Q4 24 | $-108.6M | $90.5M | ||
| Q3 24 | $-28.9M | $21.3M | ||
| Q2 24 | $-30.0M | $25.9M |
| Q1 26 | — | — | ||
| Q4 25 | $-44.6M | $92.3M | ||
| Q3 25 | $-61.5M | $21.4M | ||
| Q2 25 | $-45.8M | $32.3M | ||
| Q1 25 | $-22.2M | $19.6M | ||
| Q4 24 | $-187.0M | $75.4M | ||
| Q3 24 | $-47.4M | $15.6M | ||
| Q2 24 | $-50.1M | $21.3M |
| Q1 26 | — | — | ||
| Q4 25 | -99.4% | 121.0% | ||
| Q3 25 | -687.0% | 28.6% | ||
| Q2 25 | -267.9% | 44.3% | ||
| Q1 25 | -524.0% | 28.4% | ||
| Q4 24 | -3702.8% | 129.2% | ||
| Q3 24 | -728.4% | 23.5% | ||
| Q2 24 | -683.8% | 33.2% |
| Q1 26 | — | — | ||
| Q4 25 | 21.9% | 6.8% | ||
| Q3 25 | 99.7% | 1.2% | ||
| Q2 25 | 78.2% | 2.7% | ||
| Q1 25 | 251.1% | 1.3% | ||
| Q4 24 | 1552.7% | 25.8% | ||
| Q3 24 | 284.6% | 8.5% | ||
| Q2 24 | 274.6% | 7.3% |
| Q1 26 | — | — | ||
| Q4 25 | — | 4.26× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.88× | ||
| Q1 25 | — | 1.15× | ||
| Q4 24 | — | 7.98× | ||
| Q3 24 | — | 1.60× | ||
| Q2 24 | — | 1.64× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
